Clinical Trial Update: Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an electronic training program for orienting and interpreting [18F]Flutemetamol PET images; results were posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• [18F]Flutemetamol (flutemetamol F-18)

Snippet

Sponsor: GE Healthcare | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 3 | Status: COMPLETED | Results posted: 2013-12-19